HDAC1 Acetylation Is Linked to Progressive Modulation of Steroid Receptor-Induced Gene Transcription

Molecular Cell

Volumn 22, Issue 5, 2006, Pages 669-679

  Qiu, Yi ^a   Zhao, Yingming ^d   Becker, Matthias ^a   John, Sam ^a   Parekh, Bhavin S ^c   Huang, Suming ^b   Hendarwanto, Anindya ^a   Martinez, Elisabeth D ^a   Chen, Yue ^d   Lu, Hanxin ^a   Adkins, Nicholas L ^e   Stavreva, Diana A ^a   Wiench, Malgorzata ^a   Georgel, Philippe T ^e   Schiltz, R Louis ^a   Hager, Gordon L ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^c ELI LILLY AND COMPANY   (United States)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^e MARSHALL UNIVERSITY   (United States)

Author keywords

DNA

Indexed keywords

GLUCOCORTICOID RECEPTOR; HISTONE DEACETYLASE 1; STEROID RECEPTOR;

ACETYLATION; ANIMAL CELL; ARTICLE; CELL FRACTIONATION; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME ACTIVATION; ENZYME ACTIVITY; GENE CONTROL; GENE MUTATION; GENETIC TRANSCRIPTION; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; PROMOTER REGION;

ACETYLATION; AMINO ACID SEQUENCE; ANIMALS; BINDING SITES; CELL CYCLE PROTEINS; CHROMATIN; DOWN-REGULATION; HELA CELLS; HISTONE ACETYLTRANSFERASES; HISTONE DEACETYLASES; HUMANS; LIGANDS; MAMMARY TUMOR VIRUS, MOUSE; MICE; MODELS, GENETIC; MOLECULAR SEQUENCE DATA; NIH 3T3 CELLS; PROMOTER REGIONS (GENETICS); RECEPTORS, GLUCOCORTICOID; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED;

EID: 33744510851     PISSN: 10972765     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molcel.2006.04.019     Document Type: Article

References (42)

1. Arts J., Lansink M., Grimbergen J., Toet K.H., and Kooistra T. Stimulation of tissue-type plasminogen activator gene expression by sodium butyrate and trichostatin A in human endothelial cells involves histone acetylation. Biochem. J. 310 (1995) 171-176
2. Becker M., Baumann C.T., John S., Walker D., Vigneron M., McNally J.G., and Hager G.L. Dynamic behavior of transcription factors on a natural promoter in living cells. EMBO Rep. 3 (2002) 1188-1194
3. Bresnick E.H., John S., Berard D.S., Lefebvre P., and Hager G.L. Glucocorticoid receptor-dependent disruption of a specific nucleosome on the mouse mammary tumor virus promoter is prevented by sodium butyrate. Proc. Natl. Acad. Sci. USA 87 (1990) 3977-3981
4. Bresnick E.H., John S., and Hager G.L. Histone hyperacetylation does not alter the position or stability of phased nucleosomes on the MMTV LTR. Biochemistry 30 (1991) 3490-3497
5. Buggy J.J., Sideris M.L., Mak P., Lorimer D.D., McIntosh B., and Clark J.M. Cloning and characterization of a novel human histone deacetylase, HDAC8. Biochem. J. 350 (2000) 199-205
6. Chang S., and Pikaard C.S. Transcript profiling in Arabidopsis reveals complex responses to global inhibition of DNA methylation and histone deacetylation. J. Biol. Chem. 280 (2005) 796-804
7. Cho Y., Griswold A., Campbell C., and Min K.T. Individual histone deacetylases in Drosophila modulate transcription of distinct genes. Genomics 86 (2005) 606-617
8. David G., Neptune M.A., and DePinho R.A. SUMO-1 modification of histone deacetylase 1 (HDAC1) modulates its biological activities. J. Biol. Chem. 277 (2002) 23658-23663
9. Ferguson M., Henry P.A., and Currie R.A. Histone deacetylase inhibition is associated with transcriptional repression of the Hmga2 gene. Nucleic Acids Res. 31 (2003) 3123-3133
10. Finnin M.S., Donigian J.R., Cohen A., Richon V.M., Rifkind R.A., Marks P.A., Breslow R., and Pavletich N.P. Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors. Nature 401 (1999) 188-193
11. Georgel P.T., and Hansen J.C. Biophysical analysis of specific genomic loci assembled as chromatin in vivo. Methods Enzymol. 376 (2004) 17-29
12. Georgel P.T., Fletcher T.M., Hager G.L., and Hansen J.C. Formation of higher-order secondary and tertiary chromatin structures by genomic mouse mammary tumor virus promoters. Genes Dev. 17 (2003) 1617-1629
13. Gregoretti I.V., Lee Y.M., and Goodson H.V. Molecular evolution of the histone deacetylase family: functional implications of phylogenetic analysis. J. Mol. Biol. 338 (2004) 17-31
14. Grozinger C.M., and Schreiber S.L. Deacetylase enzymes: biological functions and the use of small-molecule inhibitors. Chem. Biol. 9 (2002) 3-16
15. Hu X., and Lazar M.A. Transcriptional repression by nuclear hormone receptors. Trends Endocrinol. Metab. 11 (2000) 6-10
16. Kramer P., Fragoso G., Pennie W.D., Htun H., Hager G.L., and Sinden R.R. Transcriptional state of the mouse mammary tumor virus promoter can effect topological domain size in vivo. J. Biol. Chem. 274 (1999) 28590-28597
17. Lallemand F. Direct inhibition of the expression of cyclin D1 gene by sodium butyrate. Biochem. Biophys. Res. Commun. 229 (1996) 163-169
18. Laribee R.N., and Klemsz M.J. Loss of PU.1 expression following inhibition of histone deacetylases. J. Immunol. 167 (2001) 5160-5166
19. Lee H.L., and Archer T.K. Prolonged glucocorticoid exposure dephosphorylates histone H1 and inactivates the MMTV promoter. EMBO J. 17 (1998) 1454-1466
20. Lefebvre P., Berard D.S., Cordingley M.G., and Hager G.L. Two regions of the mouse mammary tumor virus LTR regulate the activity of its promoter in mammary cell lines. Mol. Cell. Biol. 11 (1991) 2529-2537
21. McKnight G.S., Hager L., and Palmiter R.D. Butyrate and related inhibitors of histone deacetylation block the induction of egg white genes by steroid hormones. Cell 22 (1980) 469-477
22. McNally J.G., Mueller W.G., Walker D., Wolford R.G., and Hager G.L. The glucocorticoid receptor: rapid exchange with regulatory sites in living cells. Science 287 (2000) 1262-1265
23. Millar C.B., Kurdistani S.K., and Grunstein M. Acetylation of yeast histone H4 lysine 16: a switch for protein interactions in heterochromatin and euchromatin. Cold Spring Harb. Symp. Quant. Biol. 69 (2004) 193-200
24. Mulholland N.M., Soeth E., and Smith C.L. Inhibition of MMTV transcription by HDAC inhibitors occurs independent of changes in chromatin remodeling and increased histone acetylation. Oncogene 22 (2003) 4807-4818
25. Ng H.H., and Bird A. Histone deacetylases: silencers for hire. Trends Biochem. Sci. 25 (2000) 121-126
26. Plesko M.M., Hargrove J.L., Granner D.K., and Chalkley R. Inhibition by sodium butyrate of enzyme induction by glucocorticoids and dibutyryl cyclic AMP. A role for the rapid form of histone acetylation. J. Biol. Chem. 258 (1983) 13738-13744
27. Reid G., Metivier R., Lin C.Y., Denger S., Ibberson D., Ivacevic T., Brand H., Benes V., Liu E.T., and Gannon F. Multiple mechanisms induce transcriptional silencing of a subset of genes, including oestrogen receptor alpha, in response to deacetylase inhibition by valproic acid and trichostatin A. Oncogene 24 (2005) 4894-4907
28. Sengupta N., and Seto E. Regulation of histone deacetylase activities. J. Cell. Biochem. 93 (2004) 57-67
29. Shaner N.C., Campbell R.E., Steinbach P.A., Giepmans B.N., Palmer A.E., and Tsien R.Y. Improved monomeric red, orange and yellow fluorescent proteins derived from Discosoma sp. red fluorescent protein. Nat. Biotechnol. 22 (2004) 1567-1572
30. Sheppard K.A., Phelps K.M., Williams A.J., Thanos D., Glass C.K., Rosenfeld M.G., Gerritsen M.E., and Collins T. Nuclear integration of glucocorticoid receptor and nuclear factor-kappaB signaling by CREB-binding protein and steroid receptor coactivator-1. J. Biol. Chem. 273 (1998) 29291-29294
31. Siavoshian S., Segain J.P., Kornprobst M., Bonnet C., Cherbut C., Galmiche J.P., and Blottiere H.M. Butyrate and trichostatin A effects on the proliferation/differentiation of human intestinal epithelial cells: induction of cyclin D3 and p21 expression. Gut 46 (2000) 507-514
32. Somoza J.R., Skene R.J., Katz B.A., Mol C., Ho J.D., Jennings A.J., Luong C., Arvai A., Buggy J.J., Chi E., et al. Structural snapshots of human HDAC8 provide insights into the class I histone deacetylases. Structure 12 (2004) 1325-1334
33. Sterner D.E., and Berger S.L. Acetylation of histones and transcription-related factors. Microbiol. Mol. Biol. Rev. 64 (2000) 435-459
34. Strahl B.D., and Allis C.D. The language of covalent histone modifications. Nature 403 (2000) 41-45
35. Struhl K. Histone acetylation and transcriptional regulatory mechanisms. Genes Dev. 12 (1998) 599-606
36. Tsai C.C., and Fondell J.D. Nuclear receptor recruitment of histone-modifying enzymes to target gene promoters. Vitam. Horm. 68 (2004) 93-122
37. Turner B.M., and O'Neill L.P. Histone acetylation in chromatin and chromosomes. Semin. Cell Biol. 6 (1995) 229-236
38. Vannini A., Volpari C., Filocamo G., Casavola E.C., Brunetti M., Renzoni D., Chakravarty P., Paolini C., De F.R., Gallinari P., et al. Crystal structure of a eukaryotic zinc-dependent histone deacetylase, human HDAC8, complexed with a hydroxamic acid inhibitor. Proc. Natl. Acad. Sci. USA 101 (2004) 15064-15069
39. Wade P.A., and Wolffe A.P. Histone acetyltransferases in control. Curr. Biol. 7 (1997) R82-R84
40. Walker D., Htun H., and Hager G.L. Using inducible vectors to study intracellular trafficking of GFP-tagged steroid/nuclear receptors in living cells. Methods 19 (1999) 386-393
41. Wang X.Q., Alfaro M.L., Evans G.F., and Zuckerman S.H. Histone deacetylase inhibition results in decreased macrophage CD9 expression. Biochem. Biophys. Res. Commun. 294 (2002) 660-666
42. Xu L., Glass C.K., and Rosenfeld M.G. Coactivator and corepressor complexes in nuclear receptor function. Curr. Opin. Genet. Dev. 9 (1999) 140-147